LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
LKFT
82 hedge funds and large institutions have $894M invested in Lakefront Biotherapeutics American Depositary Shares in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
2.01% less ownership
Funds ownership: 19.51% → 17.5% (-2%)
37% less call options, than puts
Call options by funds: $1.28M | Put options by funds: $2.03M
Holders
82
Holding in Top 10
–
Calls
$1.28M
Puts
$2.03M
Top Buyers
| 1 | +$9.4M | |
| 2 | +$4.6M | |
| 3 | +$4.57M | |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$2.83M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
+$2.7M |
Top Sellers
| 1 | -$72.3M | |
| 2 | -$12.9M | |
| 3 | -$11.4M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$10.3M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.09M |